Related Experiment Video
Updated: Apr 1, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Case report: Osmotic demyelination syndrome owing to rapid correction of hyperosmolar hyperglycaemia
Lavinay Kumar Singh1, Anupama Tandon2
1Resident, Department of Radiology, University College of Medical Sciences, Delhi, India.
Abstract:
Osmotic demyelination syndrome (ODS) is a rare complication in hospitalised patients, most commonly associated with rapid correction of hyponatraemia. While being uncommon, it is a dangerous problem that could result in death or severe disability. It has been mostly associated with rapid correction of hyponatraemia. However, few reports have shown it in complicated diabetes mellitus, either during rapid correction of hyperglycaemia or at any time during the course of the disease. ODS is a non-inflammatory demyelination of neurons caused by oligodendrocyte apoptosis and macrophage infiltration which degrades myelin. ODS is divided into two categories: central pontine myelinolysis and extrapontine myelinolysis based on the site of demyelination. It is important to raise awareness of ODS among clinicians, particularly when correcting hyperglycaemia.
Related Concept Videos
Hypoglycemia and Glucagon
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Nephrotic Syndrome I : Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

